non-melanoma skin cancer

News

FDA clears AI skin cancer detection device from DermaSensor

Medtech company DermaSensor has claimed FDA approval for a handheld device, powered by artificial intelligence (AI), that can be used to detect skin cancer at the point of

Oncology

Sanofi is calling for a comprehensive, UK guideline to impro...

Non-melanoma skin cancer (NMSC) is the most common cancer in the UK, with more than 155,000 cases of NMSC reported in the UK every year.1,2 However, NMSC is significantly under-r

Oncology

Need for non-melanoma skin cancer guideline never greater

Non-melanoma skin cancer (NMSC) is the most common cancer in the UK, more than breast, bowel, and prostate cancer combined.

FDA clears AI skin cancer detection device from DermaSensor

Sanofi is calling for a comprehensive, UK guideline to impro...

Need for non-melanoma skin cancer guideline never greater

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

non-melanoma skin cancer

Editor's Picks